Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The determinants of left ventricular hypertrophy defined by Sokolow–Lyon criteria in untreated hypertensive patients

Journal of Human Hypertension volume 17, pages 159–164 (2003)Cite this article

Abstract

Left ventricular hypertrophy (LVH) measured by electrocardiography (ECG LVH) in hypertensive patients has been shown to be associated with an increased risk of cardiovascular sequelae. Analysis of the determinants predisposing to ECG LVH may be helpful in the prevention of LVH. The Department of Health and Social Security Hypertension Care Computer Project studied 2994 hypertensive patients in whom an electrocardiogram was recorded while not on treatment. LVH was determined as the voltage sum SV1+RV5 or RV6≥35 mm using Sokolow–Lyon voltage criteria. The relations were determined between the presence of LVH or voltage sum and different variables. Untreated systolic (SBP) and diastolic (DBP) blood pressure and pulse pressure were positively related to the increasing ECG voltage, while body mass index (BMI) and serum cholesterol were inversely related. Blood glucose and age did not correlate significantly. Patients with the presence of ECG LVH were more often men, black people, smokers and users of alcohol. In multiple logistic regression analyses, SBP, DBP, male gender and black race were positively, whereas BMI was negatively related to the presence of LVH. The positive relation of smoking and negative relation of serum cholesterol concentration to the presence of ECG LVH were apparent in men but not in women. This study confirms the adverse association between ECG LVH and SBP and DBP, male gender, black race and decreased BMI. It also addresses the less well-known associations of blood glucose, cholesterol, smoking and alcohol consumption.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kannel WB . Left ventricular hypertrophy as a risk factor: the Framingham experience. J Hypertens 1991; 9 (suppl 2): S3–S9.

    Article  CAS  Google Scholar 

  2. Devereux RB et al. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 1993; 14 (Suppl D): 8–15.

    Article  PubMed  Google Scholar 

  3. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446.

  4. Sokolow M, Lyon TP . The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limbs leads. Am Heart J 1949; 37: 161–186.

    Article  CAS  PubMed  Google Scholar 

  5. Mathew J et al for the Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by angiotensin-converting enzyme inhibitor ramipril. Circulation 2001; 104: 1615–1621.

    Article  CAS  PubMed  Google Scholar 

  6. Dahlöf B et al for the LIFE Study group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in hypertension Study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.

    Article  PubMed  Google Scholar 

  7. Van Hoof R for the members of European Working Party on High Blood Pressure in the Elederly. Left ventricular hypertrophy in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly Trial. Am J Med 1991; 90 (Suppl 3A): 55S–59S.

    Article  CAS  PubMed  Google Scholar 

  8. Okin PM et al for the LIFE Study Investigators. Baseline characteristic in relation to electrocardiographic left ventricular hypertrophy in hypertensive patient. The Losartan Intervention for Endpoint Reduction (LIFE) in Hypertension Study. Hypertension 2000; 36: 766–773.

    Article  CAS  PubMed  Google Scholar 

  9. Lee DK et al. Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial difference in prevalence. JAMA 1992; 267: 3294–3299.

    Article  CAS  PubMed  Google Scholar 

  10. Chapman JN et al. Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient. Am J Hypertens 1999; 12: 437–442.

    Article  CAS  PubMed  Google Scholar 

  11. Jaggy C et al. Performance of classic electrocardiographic criteria for left ventricular hypertrophy in an African population. Hypertension 2000; 36: 54–61.

    Article  CAS  PubMed  Google Scholar 

  12. Crow RS et al. Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension. Results from the Treatment of Mild Hypertension Study). Am J Cardiol 1995; 75: 1233–1238.

    Article  CAS  PubMed  Google Scholar 

  13. Rautaharju PM et al. Race and sex-specific ECG models for left ventricular mass in older populations. Factors influencing overestimation of left ventricular hypertrophy prevalence by ECG criteria in African-Americans. J Electrocardiol 2000; 33: 205–218.

    Article  CAS  PubMed  Google Scholar 

  14. Itsimishu T et al. Effect on alcohol intake on organ injuries in normotensive and hypertensive human subjects. Clin Sci 1997; 93: 541–547.

    Article  Google Scholar 

  15. Verdeccia P et al. Prognostic value of new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 1998; 31: 383–390.

    Article  Google Scholar 

  16. de Simone G, Devereux RB, Daniels SR, Meyer RA . Gender differences in left ventricular growth. Hypertension 1995; 26: 979–983.

    Article  CAS  PubMed  Google Scholar 

  17. Levy D et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors (the Framingham Heart Study). Ann Int Med 1988; 108: 7–13.

    Article  CAS  PubMed  Google Scholar 

  18. Shub C et al. Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size. Mayo Clin Proc 1994; 69: 205–211.

    Article  CAS  PubMed  Google Scholar 

  19. Savage DD et al. The spectrum of left ventricular hypertrophy in a general population sample: The Framingham Study. Circulation 1987; 75 (suppl I): I-26–I-33.

    CAS  Google Scholar 

  20. Levy D et al. Prognostic implications of echocardiographically determined left ventricular mass in Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.

    Article  CAS  PubMed  Google Scholar 

  21. Hammond IW et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639–650.

    Article  CAS  PubMed  Google Scholar 

  22. Liao Y, Cooper RS, Mensah GA, McGee DL . Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995; 92: 805–810.

    Article  CAS  PubMed  Google Scholar 

  23. Gottdiener J et al. for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol 1994; 24: 1492–1498.

    Article  CAS  PubMed  Google Scholar 

  24. Lauer MS, Anderson KM, Levy D . Separate and joint influences of obesity and mild hypertension on left ventricular mass geometry: The Framingham Heart Study. J Am Coll Cardiol 1992; 19: 130–134.

    Article  CAS  PubMed  Google Scholar 

  25. de Simone G et al. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994; 23: 600–606.

    Article  CAS  PubMed  Google Scholar 

  26. Abergel E, Tase M, Menard J, Chatellier G . Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy. Am J Cardiol 1996; 77: 739–744.

    Article  CAS  PubMed  Google Scholar 

  27. Okin PM, Roman M, Devereux RB, Kligfield P . Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity. J Am Coll Cardiol 1996; 27: 124–131.

    Article  CAS  PubMed  Google Scholar 

  28. Okin PM et al for the Life Study Group. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients. The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study. Hypertension 2000; 35: 13–18.

    Article  CAS  PubMed  Google Scholar 

  29. Rautaharju PM, Park L, Rautaharju FS, Crow R . A standardised procedure for locating and documenting ECG chest electrode position: consideration of the effect of breast tissue on ECG amplitudes in women. J Electrocardiol 1998; 31; 17–29.

    Article  CAS  PubMed  Google Scholar 

  30. Devereux RB et al. Impact of diabetes on cardiac structure and function. The Strong Heart Study. Circulation 2000; 101: 2271–2276.

    Article  CAS  PubMed  Google Scholar 

  31. Palmieri V et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects. Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation 2001; 103: 102–107.

    Article  CAS  PubMed  Google Scholar 

  32. National task forces on the prevention and treatment of obesity. Overweight, obesity, and health risk. Arch Intern Med 2000; 160: 898–904.

  33. Reichek N, Devereux RB . Left ventricular hypertrophy: Relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981; 63; 1391–1398.

    Article  CAS  PubMed  Google Scholar 

  34. Levy D et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81:815–820.

    Article  CAS  PubMed  Google Scholar 

  35. Okin PM, Roman MJ, Devereux RB, Klingfield P . Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995; 25: 417–423.

    Article  CAS  PubMed  Google Scholar 

  36. Beilin LJ et al. Computer-based hypertension clinic records: A co-operative study. Br Med J 1974; 2: 212–216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bulpitt CJ et al. Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J 1976; 1: 677–679.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Imperial College School of Medicine, London, UK

    R Antikainen, T Grodzicki, A J Palmer & C J Bulpitt

  2. City Hospital, Birmingham, UK

    D G Beevers

  3. University of Wales College of Medicine, Cardiff, UK

    E C Coles

  4. Aberdeen Royal Infirmary, Aberdeen, UK

    J Webster

  5. Department of Internal Medicine, University of Oulu and Oulu City Hospital, Oulu, Finland

    R Antikainen

  6. Jagiellonian University, Cracow, Poland

    T Grodzicki

Authors
  1. R Antikainen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Grodzicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A J Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D G Beevers
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E C Coles
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Webster
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C J Bulpitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Antikainen.

Additional information

Support: This study was supported by grants from the Finnish Medical Foundation and the U.K. Department of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antikainen, R., Grodzicki, T., Palmer, A. et al. The determinants of left ventricular hypertrophy defined by Sokolow–Lyon criteria in untreated hypertensive patients. J Hum Hypertens 17, 159–164 (2003). https://doi.org/10.1038/sj.jhh.1001523

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001523

Keywords

This article is cited by

Search

Advanced search

Quick links